Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial

BACKGROUND: Protease inhibitor (PI)-based therapy is recommended as first-line treatment for HIV-infected infants exposed to nevirapine prophylaxis. However, long-term use poses adherence challenges, is associated with metabolic toxicities, limits second-line options, and is costly. We report long-t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Kuhn, Louise, Coovadia, Ashraf, Strehlau, Renate, Martens, Leigh, Hu, Chih-Chi, Meyers, Tammy, Sherman, Gayle, Hunt, Gillian, Persaud, Deborah, Morris, Lynn, Tsai, Wei-Yann, Abrams, Elaine J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539971/
https://ncbi.nlm.nih.gov/pubmed/22424722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(12)70051-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados